Tag Archives: Cheray Lynch Sieminski

PODs: Proceed with Extreme Caution

By Edward J. Buthusiem, Cheray Lynch Sieminski, Vahan Minassian

U.S. legislators and enforcement agencies have grown increasingly concerned with physician-owned distributors (PODs) and their relationship with hospitals and other providers. Because physicians may refer patients to hospitals—and use specific products in connection with such referrals—the government asserts that PODs have the potential to unduly influence physician decision making, encourage overutilization of certain products and services, create unfair competition and otherwise increase unnecessary healthcare spending by Federal programs.

Continue reading PODs: Proceed with Extreme Caution

Five Steps to Sunshine: Strategies for Complying with CMS Reporting Requirements

By Edward J. Buthusiem, Cheray Lynch Sieminski, Vahan Minassian

U.S. and global regulators heavily scrutinize financial arrangements between healthcare professionals (HCPs) and life sciences companies, including orthopaedic manufacturers and distributors. Recent prosecutions and settlements involving drug and device manufacturers frequently allege that certain payments and other incentives provided to physicians are being improperly made in order to promote their products. Indeed, several prominent medical device companies have been subject to investigations and corporate integrity agreements stemming from alleged improper consulting payment arrangements with physicians.[^1]

Continue reading Five Steps to Sunshine: Strategies for Complying with CMS Reporting Requirements